Suspension of Italian medtech price cuts upheld

05/14/2013 | Clinica

An Italian court ruling has upheld the suspension of a government mandate to cut prices for medical devices, invalidating the program that was scheduled to go into effect in January. The court found that the price cuts were based on a faulty use of the national medical device classification system and used inaccurate price sampling. Italian health care authorities must now come up with a different formula for implementing cost controls that recognizes the varied and specialized characteristics of the medtech sector.

View Full Article in:

Clinica

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC